As an example, miR-26a was first shown to promote ovarian cancer proliferation through its suppression of ER-α [481], while subsequently, it was shown to inhibit proliferation of ovarian cancer cells through its regulation of CDC6 [482]. This evidence concerns the gene CDC6 and ovarian carcinoma.